兴瑞科技(002937) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was ¥312,276,774.72, representing a 47.81% increase compared to ¥211,273,245.87 in the same period last year[8]. - Net profit attributable to shareholders for Q1 2021 was ¥37,344,717.39, up 51.82% from ¥24,597,801.11 in the previous year[8]. - The net profit after deducting non-recurring gains and losses was ¥37,614,056.20, reflecting a 68.06% increase from ¥22,381,302.92 year-on-year[8]. - Basic earnings per share for Q1 2021 were ¥0.13, an increase of 62.50% from ¥0.08 in the previous year[8]. - The company's revenue for Q1 2021 was approximately $312.28 million, representing a 47.81% increase compared to Q1 2020's revenue of $211.27 million[19]. - The company reported a significant increase in other income, which rose by 1478.32% to approximately $209,162 in Q1 2021, compared to $13,252 in Q1 2020[19]. - The total profit for the current period was ¥41,808,489.66, compared to ¥28,204,039.86 in the previous period, representing an increase of about 48.1%[83]. Cash Flow - The net cash flow from operating activities was ¥18,428,182.05, a significant improvement of 219.98% compared to a negative cash flow of -¥15,359,650.40 in the same period last year[8]. - The net cash flow from operating activities for Q1 2021 was approximately $18.43 million, a significant increase of 219.98% compared to a negative cash flow of $15.36 million in Q1 2020[24][25]. - The cash outflow for investing activities was CNY 76,498,221.58, compared to CNY 174,614,109.35 in the previous year, indicating a reduction in investment spending[97]. - The net cash flow from investing activities was -22,865,953.56 CNY, a decrease compared to -80,276,015.15 CNY in the previous period[101]. - The total cash inflow from financing activities was 21,885,500.00 CNY, while the cash outflow was 12,679,609.21 CNY, resulting in a net cash flow of 9,205,890.79 CNY[101]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,301,779,804.85, a 2.99% increase from ¥1,264,029,860.68 at the end of the previous year[8]. - Current liabilities rose to CNY 271,801,621.88, compared to CNY 261,548,602.41, indicating an increase of approximately 4.8%[72]. - Total liabilities amounted to CNY 272,186,661.74, up from CNY 261,908,106.40, marking a growth of around 3.5%[72]. - The company’s long-term equity investments rose to CNY 407,576,542.25 from CNY 390,044,199.05, indicating an increase of approximately 4.5%[76]. - The company's current assets totaled RMB 936.15 million, an increase from RMB 915.34 million at the end of 2020[68]. Shareholder Information - The company had a total of 16,552 common shareholders at the end of the reporting period[13]. - The largest shareholder, Ningbo Zheqi Investment Management Co., Ltd., held 24.29% of the shares, with a total of 72,259,670 shares[13]. - The company approved the 2021 employee stock ownership plan, allowing for the repurchase of up to 1,000,020 shares, representing 0.34% of the total share capital[34]. - The total amount allocated for the share repurchase plan is between RMB 12.20 million and RMB 22.80 million, with a repurchase price range of RMB 12.20 to RMB 19.00 per share[34]. Subsidiaries and Expansion - The company established a subsidiary in Indonesia with a registered capital of approximately $3.5 million to enhance market presence and service overseas clients[26]. - A new wholly-owned subsidiary was set up in Shanghai with a registered capital of approximately $280,000 to improve the sales and procurement system[27]. - The company established a wholly-owned subsidiary in Indonesia as part of its expansion strategy[34]. - The company also set up a wholly-owned subsidiary in Shanghai, furthering its market expansion efforts[34]. Risk Management and Compliance - The company has established a comprehensive hedging management system to mitigate risks associated with foreign exchange fluctuations[51]. - The company’s risk control measures include a clear disclosure system for derivative investments[51]. - The company has not experienced significant changes in its accounting policies for derivatives compared to the previous reporting period[51]. - The company has no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[43]. - There are no violations regarding external guarantees reported during the period[58]. Research and Development - Research and development expenses were reported at ¥12,758,619.80, an increase from ¥11,426,586.86, showing a growth of approximately 11.6%[81].